Metabolic Health Summit 2026
LUDHIANA — The Society for Training in Endocrine & Diabetes Research (STEADY) organized the Metabolic Health Summit 2026 at Hotel Maharaja Regency, Ludhiana. The academic conference brought together leading medical specialists to deliberate on breakthrough therapeutic approaches and cutting-edge management strategies for type 2 diabetes and obesity.
The summit focused on educating medical practitioners on emerging pharmacological advancements, with a particular spotlight on novel dual incretin-based therapies (GIP and GLP-1 receptor agonists like Tirzepatide) designed to transform metabolic disorder management.
A multidisciplinary panel discussion on the "Role of Dual Incretin-Based Therapies in Cardiometabolic Disorders" rounded out the evening. The panel featured perspectives from diverse clinical specialties, emphasizing comprehensive, collaborative patient care:
- Dr. Gurpreet Singh (Pulmonologist, Deep Hospital)
- Dr. C.S. Grewal (Gastroenterologist, SAS Grewal Hospital)
- Dr. H.S. Jolly (Director – Metabolic & Bariatric Surgery, Prolife Hospital)
- Dr. Ravninder Singh Kuka (Deputy Director & Interventional Cardiologist, SPS Hospital)
- Dr. B.S. Hunjan (Orthopedic Surgeon, Hunjan Hospital)
- Dr. Saurabh Arora (Endocrinologist, Fortis Hospital, Ludhiana)
The summit concluded with a dynamic question-and-answer session, reinforcing STEADY Society's ongoing commitment to continuous medical education and bridging clinical research with day-to-day patient care.
